Portfolio Choice     

Published: March 15, 2026
Updated: March 15, 2026

NATCO PHARMA
BSE ticker code 524816
NSE ticker code NATCOPHARM
Major activity Pharmaceuticals
CMD Venkaiah Chowdary Nannapaneni
Equity capital Rs 35.82 crore; FV Rs 02
52 week high/low Rs 1060 / Rs 660
CMP Rs 888.65
Market Capitalisation Rs 15916.60 crore
Recommendation Accumulate
Robust inventory of generic drugs

Hyderabad-headquartered Natco Pharma is a globally recognised, vertically integrated and R&D-focused generic drug manufacturing company engaged in the development and manufacture of high-quality and niche finished dosage forms (FDF) and active pharmaceutical ingredients (API). It has established its presence in all three business segments — FDF, API and contract manufacturing.

Focused on the niche pipeline to drive growth over the years, Natco has constantly showcased its expertise through the launch of niche, highvalue products including Para IV and first-to-file (FTF) products in India and the US while expanding into new geographies. The company follows a blockbuster launch strategy focusing on complex, high-barrier-to-entry generics and niche molecules, leveraging its R&D capabilities to develop challenging difficult-to-manufacture products.

Notable blockbuster products launched in the past include generic Revlimid, Glatiramer Acetate injection, Liposomal Doxorubicin, Sofosbuvir for Hepatitis-C and Dabigatran.

The management has reiterated its commitment to building a robust and niche product pipeline to drive sustained earnings, growth. Following the successful launch of generic revlimid, the company is optimistic about unlocking additional significant opportunities over the next couple of years. A key highlight of Natco’s strategy is its focus on the US market, where its pipeline is particularly strong, emphasising complex generics and first-to-file (FTF) opportunities. These high-barrier-entry products, such as semaglutide injections for diabetes and weight loss, are central to the company’s growth strategy.

SALES SKYROCKET

Natco has made rapid growth in its financial performance. During the last 12 years, its sales turnover has surged over six times from Rs 739 crore in fiscal 2014 to Rs 4,430 crore in fiscal 2025, with operating profit shooting up over 12 times from Rs 179 crore to Rs 2,196 crore and the net profit taking a jump of around 20 times from Rs 1,798 crore to Rs 1,883 crore. What is more, prospects ahead are all the more encouraging. Consider:

  • The company has chalked out a strategy which pivots towards future growth engines. In order to ensure that its focused niche pipeline drives growth over the years, Natco has consistently showcased its expertise through the launch of niche, high-value blockbuster products, including generic Revlimid, Glatiramer Acetate injection, Lipusomal, Doxorubicin, Sofosbuvir for Hepatitis-C and Dabigatran. Now, a key highlight is the anticipated launch of Semaglutide in India, pending approval from the Drug Controller General of India. Approvals for branded versions like Ozempic and Wegovy are expected very soon. Other critical products in the queue are Erdafitinib and Olaparib.
SEEKING M&As
  • Besides launching new products, the company has emphasised a significant push into mergers & acquisitions, holding approximately Rs 2,500 crore in net cash. The management is exploring a couple of large acquisitions in calendar year 2026, similar in scale to its previous investment in Adcock Ingram, with a strategic focus on emerging markets and established brand business outside India.
  • The new products already launched have started contributing to the company's topline and bottomline. During the first three quarters of the current fiscal, revenues have amounted to Rs 3,559 crore with a net profit of Rs 1,150 crore. The management has set a guidance of Rs 4,200-4,300 crore for revenues and Rs 1,280-1,300 crore for net profit for the whole of fiscal year 2026. What is more, the management has set an ambitious target of revenues worth Rs 10,000 crore within the next 5 to 10 years.

The company's financial position is very strong, with reserves at the end of September 2025 standing at Rs 8,614 crore - almost 240 times its equity capital of Rs 36 crore. It has reduced its borrowings from Rs 416 crore in fiscal 2022 to Rs 261 crore by September 2025. Its interest burden is nominal - just Rs 36 crore in the context of sales of Rs 4,560 crore. What is more, it has a net cash balance of Rs 2,500 crore. Natco subsidiaries, particularly in Canada and Brazil, are doing very well. The management expects growth momentum in the subsidiaries to continue as the latter have a good pipeline of products pending approval.

CROP FORAY

The company made its maiden entry into the crop protection space with the launch of a pheromone product, Natmate. It also launched CTPR pesticides subsequently. The management has set a crop sciences business revenue target of Rs 120-150 crore for fiscal 2026.

  • The Natco stock was going strong and had reached a high of Rs 1,639 (face value Rs 2). But a highly disappointing performance during Q3FY2025 generated a selling wave which brought down the stock price to Rs 660. However, the lower levels attracted knowledgeable buying and the share price recovered to Rs 890.
  • During the current bearish phase in the market, the share price may decline modestly from the current levels. But the long-term prospects are highly encouraging and discerning investors will do well to accumulate these stocks at every decline. Investors with patience will reap a rich harvest in the long run.

PERFORMANCE INDICATORS (Rs. in crore)

Year Net Sales Net Profit EPS (Rs.) Div (%) BV (%)
2024-25 4429.50 1884.25 105.20 300.0 482.90
2025-26 (E) 4643.26 1976.42 109.44 300.0 491.40
2026-27 (E) 4931.56 2069.42 112.46 325.0 496.52
SIGNPOST INDIA
BSE ticker code 544117
NSE ticker code SIGNPOST
Major activity Advertising & Media
Chairman Girish Pandurang Kulkarni
Equity capital Rs 10.69 crore; FV Rs 02
52 week high/low Rs 312 / Rs 179
CMP Rs 242.00
Market Capitalisation Rs 1293.49 crore
Recommendation Accumulate at declines
Pole player in India’s digital ad space

One of the leading players in India’s out-of-home (OOH) advertising space, Signpost India is among the top three players nationwide. Since its inception in 2008, the Mumbai-headquartered company has expanded across locations, including Delhi, Bangalore, Chennai, Kolkata, Nagpur, Pune, Nashik and Aurangabad. Today, it operates more than 12,500 advertising assets across more than 25 cities, including ads at transit locations (like airports, metros), bus shelters and city roads, digital screens and traditional outdoor billboards, catering to over 1,600 active clients.

The company uses all such places for display of advertisements through design technology, data analytics and content provision. With demonstrable experience, it engineers end-to-end mega projects to build public places that ensure commuter convenience, ergonomic roofing and priority seating, tactile flooring, accessibility ramps, charging stations, laboratories, SOS integration, notifications of upcoming buses, and more.

The company has long-term plans averaging 14 years and uses its in-house captive media platform to plan and direct relationships and over 25,000 premium digital panels. It boasts of a strong clientele list with names like Sony, Samsung, Nestle, Havells, Air Asia, TVS, Viacom, Zepto, Sketchers and WeWork.

Its digital spaces have driven multi-city campaigns for brands, garnering recognition across both national and international arenas for innovation, design, sustenance and engineering and receiving awards in numerous categories, including 57 golds, 43 silvers and 28 bronzes from prestigious bodies like the Abbys, the London Digital Signage Awards, and the Kyoorius awards.

SALES BOOM

Needless to say, the company has made rapid strides on the financial front since its inception in 2008 and its listing on BSE and NSE in 2021. The sales turnover, which had shot up from Rs 43 crore in 2015 to Rs 168 crore in fiscal 2022, has during the last four years surged to Rs 525 crore in fiscal 2025. Operating profit, which had jumped 12 times from Rs 5 crore in fiscal 2012 to Rs 60 crore in fiscal 2022, climbed further to cross Rs 100 crore and reach Rs 116 crore in fiscal 2025. Net profit, which had risen from Rs 3 crore in 2015 to Rs 28 crore in 2022, skyrocketed to Rs 50 crore in 2025. What is more, prospects ahead are all the more promising Consider:

  • The company has a strong standing in its field on account of the extensive experience of its promoters and management team. The two decade-long experience of the promoters in outdoor media publicity has helped the company establish strong relationships with large advertisers on a pan-India basis and garner a strong market position. The Signpost group is expected to continue receiving strategic guidance from the promoters, while it also has a professional management team for overseeing various functions. All the directors are veterans with over two decades of experience in the industry.
  • Signpost’s strong market position is well reflected in its established position across more than 25 cities, including several formats and consistent growth. The company has been expanding its presence across locations, including Mumbai, Delhi, Bangalore, Chennai, Kolkata, Nagpur, Pune, Nashik and Aurangabad.
TIGHT SHIP
  • Signpost is known for its healthy operating efficiency. It has economical advertising properties in prime locations across various places such as skywalks, BQS (bus queue shelter), foot overbridges, self-service bicycle systems, city information panels, mobile charging terminals, digital innovations at airports, and prominent public places. This provides an edge over the competition for better pricing and occupancy Little wonder, it recently won several new contracts, such as Mumbai BQS, Mumbai Metro and Delhi Aerocity. It is also focusing on digital assets, which have a higher margin, and on reducing its share of the trading business, which has a lower margin. This practice has resulted in improvement in the overall operating margin from 14 per cent in fiscal 2022 to 23 per cent in fiscal 2023, and 26 per cent in 2025. Margins are expected to be healthy going ahead. The Signpost stock was going strong at around Rs 450 of late. But on account of the distinctly bearish trend in the market it has fallen back to around Rs 247. Observers strongly feel that once the bearish trend is over, the company will be among the first stocks to resume its upward journey and recover its earlier high level within the next 2 to 3 years.

PERFORMANCE INDICATORS (Rs. in crore)

Year Net Sales Net Profit EPS (Rs.) Div (%) BV (%)
2024-25 453.22 34.10 6.40 25.0 46.90
2025-26 (E) 469.36 36.44 6.90 25.0 48.36
2026-27 (E) 475.25 40.15 7.20 30.0 51.32
TAPARIA TOOLS
BSE ticker code 505685
NSE ticker code --
Major activity Iron & Steel Products
Chairman Narayan Tulsiram Atal
Equity capital Rs 15.18 crore; FV Rs 10
52 week high/low Rs 28 / Rs 10
CMP Rs 19.71
Market Capitalisation Rs 29.92- crore
Recommendation Buy
Toolmaker to nation, with global reach

Popularly described as ‘toolmaker to the nation’, Mumbai-headquartered Taparia Tools, set up in 1969 in technological collaboration with Banco, a reputed Swedish company, is engaged in the manufacture of top-quality hand tools. These include:

  • Adjustable wrenches (chrome-plated and phosphate finish, and with a soft grip).
  • A wide range of screw drivers, including screw drivers with a flat tip, electrician pattern, Phillips tip, Torx tip, screw driver sets, line testers, and two-in-one screw drivers.
  • Varieties of pliers. The plier family includes combination pliers, side-cutting pliers, long nose pliers, circlip pliers, water pump pliers, pincers, vice grip pliers, etc.
  • Tool sets and kits of various types.
  • Ball peen, cross peen and claw hammers.
  • Forged C-clamps in different sizes, from the smallest to the biggest.
  • Chisels in various types and sizes, including pneumatic chisels.

The company has a well laid out, fully equipped factory located at Nashik, which is a four-hour drive from Mumbai, and another expanded unit at Goa, 600 km from Mumbai.

The plant is located on a total area of 42,832 sq m. All the manufacturing facilities required for production of hand tools are under one roof. Hand tools manufacturing is complicated, involving high technology and a labour-intensive production process. Of the total workforce of 1,200, the number of people engaged in direct production is 1,000. The remaining are in administration and management.

The company’s R&D department is manned by mechanical engineers and metallurgists equipped with the latest CAD design facilities, etc. From its inception, the company has laid high emphasis on the quality of its products. It has a wellestablished quality control department to monitor different stages of production. In fact, Taparia tools meet and in some cases exceed US Federal Specifications of hardness and torque value, besides meeting Indian, British and German standards.

PAN-INDIA REACH

TTL is an undisputed leader in the space of hand tools in India, and has over 800 distributors across the country. What is more, the company is spreading its footprint overseas. By now, it exports its products to over 25 countries, including the UK, the US, Denmark, Germany, Sweden, Israel, Norway, Finland, Dubai, Kuwait, UAE, Tanzania, Kenya, Argentina, Uruguay, Hong Kong, Thailand, Mexico and Sri Lanka.

Needless to say, the company is growing steadily on the financial front. During the last 12 years, its sales turnover has expanded more than three and a half times from Rs 266 crore in fiscal 2014 to Rs 913 crore in fiscal 2025, with operating profit shooting up more than seven and a half times from Rs 20 crore to Rs 156 crore and the profit at net level surging more than 10 times from Rs 12 crore to Rs 123 crore. In the current year, sales will cross the Rs 1,000-crore mark with net profit expected to reach the Rs 150-crore level. What is, more prospects for the company going ahead are all the more promising. Consider:

  • The company’s financial position is very strong, with reserves at the end of March 2025 standing at Rs 393 crore — over 26 times its equity capital of Rs 15 crore. The company is almost debt-free with zero-level financial charges. It has delivered good profit growth of 62 per cent CAGR over the last 5 years and has been maintaining a healthy dividend payout of 62 per cent.
  • Taparia’s focus on product innovation and quality assurance has strengthened its competitive position. This, along with its strong market reputation, expansion efforts and growing demand at home from the construction and manufacturing sectors, will lead the company and its share price to new high levels. Export demand is also on the rise, especially from the US, the UK, Germany, France, Denmark, Israel, Sweden, Nor way, Finland and Dubai. This is because Taparia tools meet and some cases even exceed the US torque value, besides meeting Indian, British and German standards. The company’s tools are guaranteed against manufacturing and raw material defects and are replaced free of cost — no questions asked.
LATEST TECH
  • The company has fully absorbed the production technology of its Swedish collaboration. Its manufacturing facilities include a modern forge shop, a machine shop, heat treatment, polishing and nickel-chrome plating, among several others.
  • Taparia Tools has a design and development department with the latest CAD design facilities for the designs of products and their modifications.
  • Besides, the company is not content to sit on past laurels. It keeps abreast of the latest developments in the hand tools industry by continuously participating in international fairs and events in Europe, the US and elsewhere. The company’s share with a face value of Rs 10 is available at a throwaway price of Rs 16. Unfortunately, there is no floating stock in the market. Investors can try their luck, and if they succeed in acquiring some shares, they will reap a rich harvest going ahead.

PERFORMANCE INDICATORS (Rs. in crore)

Year Net Series Net Profit EPS (Rs.) Div (%) BV (%)
2024-25 912.89 122.55 80.70 500.0 268.90
2025-26 (E) 946.15 132.46 86.10 500.0 272.46
2026-27 (E) 998.62 138.62 88.60 500.0 280.12

March 31, 2026 - Second Issue

Industry Review

VOL XVII - 06
March 16-31, 2026

Formerly Fortune India Managing Editor Deven Malkan Assistant Editor A.K. Batha President Bhupendra Shah Circulation Executive Warren Sequeira Art Director Prakash S. Acharekar Graphic Designer Madhukar Thakur Investment Analysis CI Research Bureau Anvicon Research DD Research Bureau Manager (Special Projects) Bhagwan Bhosale Editorial Associates New Delhi Ranjana Arora Bureau Chief Kolkata Anirbahn Chawdhory Gujarat Pranav Brahmbhatt Bureau Cheif Mobile: 098251-49108 Bangalore Jaya Padmanabhan Bureau Chief Chennai S Gururajan Bureau Chief (Tamil Nadu) Ludhiana Ajitkumar Vijh Bhubaneshwar Braja Bandhu Behera

Want to Subscribe?


Lighter Vein

Popular Stories

E-Waste Dilemma Tackling E-Waste Via Reverse Logistics, By Vihaan Shah

A modern-day enigma and a ramification of humanity's never-ending advancements, e-waste refers to the scum con- cealed by the outward glow of ever-advancing technology.

Archives

About Us    Contact Us    Careers    Terms & Condition    Privacy Policy

Liability clause: The investment recommendations made here are based on the personal judgement of the authors concerned. We do not accept liability for any losses that might occur. All rights reserved. Reproduction in any manner, in whole or in part, in English or in any other language is prohibited.

Copyright © 1983-2026 Corporate India. All Rights Reserved.

www.corporateind.com | Cookie Policy | Disclaimer